XML 202 R53.htm IDEA: XBRL DOCUMENT
v3.25.2

Earning (Loss) Per Share (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2025
Earning (Loss) Per Share [Abstract] |
Schedule of Earnings (Loss) Per Share |
|  | For the years ended March 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Earning (loss) per share – basic and diluted: |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |
Net income (loss) attributable to the Company’s shareholders |  | $ | 5,587,625 |  |  | $ | (1,373,504 | ) |  | $ | 1,986,119 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Weighted average number of ordinary shares outstanding |  |  | 107,184,280 |  |  |  | 105,013,283 |  |  |  | 104,972,026 |
Earning (loss) per ordinary share – basic and diluted |  | $ | 0.05 |  |  | $ | (0.01 | ) |  | $ | 0.02 |
Schedule of Ordinary Shares Equivalents Were Excluded from the Computation to Eliminate Any Antidilutive Effect | The following ordinary shares equivalents were excluded from the computation to eliminate any antidilutive effect:
|  | As of |  |  | As of |  |  | As of |
|  | March 31, 2025 |  |  | March 31, 2024 |  |  | March 31, 2023 |
Warrant (1) |  |  | 16,500,000 |  |  |  | - |  |  |  | - |
Ordinary shares placed in escrow (2) |  |  | 4,328,394 |  |  |  | - |  |  |  | - |
(1) | For the years ended March 31, 2025, 2024, and 2023, the Company had the 16,500,000, 0, and 0 shares of warrants, respectively, outstanding which were not included in the calculation of diluted net (income) loss per ordinary share because inclusion thereof would be anti-dilutive
(2) | For the years ended March 31, 2025, 2024, and 2023, the Company had 4,328,394, 0, and 0 ordinary shares, respectively, held in escrow. The Company has determined that these shares are non-participating securities in accordance with ASC 260, as they are not entitled to dividends or other rights until certain milestones are met. As such, these shares are excluded from the calculation of basic and diluted earnings (loss) per share for the respective periods.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration